Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lokelma-supported high-potassium healthy diet in advanced chronic kidney disease
2020-000695-38Phase 4Terminated
- Sponsor
- Karolinska University Hospital
- Start
- May 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium zirconium cyclosilicate in chronic kidney disease (CKD), sponsored by Karolinska University Hospital. Primary endpoint: Patient satisfaction. Started May 2020; status: terminated.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2020-000695-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000695-38.